Quantcast

Latest Artificial heart Stories

2010-06-08 12:12:00

WALTHAM, Mass., June 8 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, national registry data presented at last month's euroPCR will drive adoption of transcatheter aortic valve implantation, as illustrated in MRG's new European Markets for Heart Valve Devices 2010 report. Presented by European physicians at the Paris conference, the encouraging registry results revealed high success rates in addition to...

2010-04-23 09:16:00

ADDISON, Texas, April 23 /PRNewswire/ -- New data show improved outcomes, better survival rates and lower costs with the use of continuous flow mechanical circulatory support devices in patients awaiting heart transplants. Research will be presented this week during symposia at the International Society for Heart and Lung Transplantation (ISHLT) 30th Annual Meeting and Scientific Session at the Hilton Chicago. Ventricular Assist Devices (VADs), or heart pumps, are used to partially or...

2010-04-13 07:07:00

WALTHAM, Mass., April 13 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers. Although percutaneous aortic valves and percutaneous mitral valves gained CE mark approval in Europe in 2007 and 2008, respectively, these devices are not expected to launch in the US market until 2011 and 2012. Percutaneous...

2010-04-07 16:19:00

FRAMINGHAM, Mass. and SYDNEY, April 7 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll up to an additional 54 patients in its "ADVANCE" bridge-to-transplant...

2010-03-12 21:17:00

LOS ANGELES, March 12 /PRNewswire/ -- For patients who are living with a heart problem, the option of surgical treatment can be just as terrifying as their current condition. From aortic aneurysms to Heart Valve Replacement Surgery, Open Heart Surgery is a serious procedure that has definite risks to the patient's health. However, with a great team of talented and experienced cardiothoracic surgeons, patients who need heart valve replacement surgery can go into surgery feeling confident....

2010-02-22 16:15:00

FRAMINGHAM, Mass. and SYDNEY, Feb. 22 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial. HeartWare's ADVANCE clinical trial is an FDA approved IDE study designed to evaluate the HeartWare® Ventricular Assist...

2010-02-12 16:27:00

HOUSTON, Feb. 12 /PRNewswire/ -- The wait is over for 16-year-old Francesco "Frank" De Santiago. On January 29, De Santiago received a donor heart in a successful nine-hour transplant operation at Texas Children's Heart Center. De Santiago made medical history last October for being the first child ever discharged from a pediatric hospital with an implanted mechanical heart pump, or intracorporeal ventricular assist device (VAD). Until then, pediatric patients with mechanical heart...

2010-01-20 12:34:00

Device Provides Support for Those Who Are Not Acceptable Transplant Candidates SILVER SPRING, Md., Jan. 20 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) The HeartMate II is already FDA-approved for use in patients...

2009-12-15 05:30:00

MINNEAPOLIS, Dec. 15 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that the United States Patent and Trademark Office has issued patent number 7,594,974 regarding a novel method of cutting tissue materials for use in implantable devices. (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO) The patent, entitled "Method of Cutting Material for Use in Implantable...

2009-12-01 17:16:00

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Artificial Organs - Worldwide Market Challenges & Opportunities http://www.reportlinker.com/p0164217/Artificial-Organs---Worldwide-Market-Challenges--Opportunities.html With decades of research and advances in technology, artificial organs have become the viable alternative to effectively address donor organ shortage problem. Besides sustaining life and...


Latest Artificial heart Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related